|
|
||||||||||||||
|
|
|||||||||||||||
The Karim Centre for
Meningitis Research, Imperial College School of Medicine, Department of
Paediatrics and Neonatal Medicine, Queen Charlotte's and Chelsea
Hospital, Goldhawk Road, London W6 0XG, UK
Correspondence to: Professor Harvey, Department of Paediatrics, Imperial College School of Medicine, Hammersmith Hospital, Ducane Road, London W12 0NN, UK david.harvey{at}ic.ac.uk
Accepted 12 October
2000
OBJECTIVES
To
determine the incidence of neonatal meningitis in England and Wales.
DESIGN
A national
postal survey using the British Paediatric Surveillance Unit (BPSU)
card scheme supplemented by information from other sources.
SETTING
England and
Wales 1996-1997.
SUBJECTS
A total of
274 babies less than 28 days of age who were treated for meningitis.
RESULTS
The incidence
of neonatal meningitis in England and Wales has not changed since our
previous study in 1985-1987. However, the acute phase mortality has
fallen from 19.8% in 1985-1987 to 6.6% in this study. Group B
streptococci (42%) and Escherichia coli
(16%) remain the most common infecting microorganisms. Eight of 69 (12%) babies with group B streptococci and 4/26 (15%) with E coli died. Antibiotic regimens based on
the third generation cephalosporins, notably cefotaxime, were most
commonly used (84%). The BPSU scheme identified 72% of cases during
the study period. Most cases of viral meningitis were not reported
through the BPSU. Less than a third of samples from aseptic meningitis
were examined for viruses; 56% of these were positive.
CONCLUSIONS
Although
the incidence of neonatal meningitis remains unchanged, mortality from
this infection has fallen significantly. If this improvement is
maintained as reflected in the level of sequelae at 5 years of age,
then the fear surrounding meningitis during the neonatal period will
have been dramatically reduced.
Relevant Article
This article has been cited by other articles:
![]() |
N. Mushtaq, M. B. Redpath, J. P. Luzio, and P. W. Taylor Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase J. Antimicrob. Chemother., July 1, 2005; 56(1): 160 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bisharat, D. W. Crook, J. Leigh, R. M. Harding, P. N. Ward, T. J. Coffey, M. C. Maiden, T. Peto, and N. Jones Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor J. Clin. Microbiol., May 1, 2004; 42(5): 2161 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Stoll, N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, et al. To Tap or Not to Tap: High Likelihood of Meningitis Without Sepsis Among Very Low Birth Weight Infants Pediatrics, May 1, 2004; 113(5): 1181 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
P T Heath, N K Nik Yusoff, and C J Baker Neonatal meningitis Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2003; 88(3): F173 - F178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. S. Philip Neonatal Meningitis in the New Millennium NeoReviews, March 1, 2003; 4(3): e73 - 80. [Full Text] [PDF] |
||||
![]() |
D Isaacs A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F89 - F93. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bedford, J. de Louvois, S. Halket, C. Peckham, R. Hurley, and D. Harvey Meningitis in infancy in England and Wales: follow up at age 5 years BMJ, September 8, 2001; 323(7312): 533 - 533. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |